Skip to main content

The Wistar Institute

|

[Hybrid] Distinguished Lectures in Cancer Research Series: The Intersection Between Cancer Biology and RNA Processing

Scientific Seminar Tuesday, Nov. 8, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of the Ellen and Ronald Caplan Cancer Center and features national and international leaders in ba…
Read more
|

The Wistar Institute One of Nation’s Top 3 Research Institutions for Innovation

PHILADELPHIA — (OCTOBER 24, 2022) — The Wistar Institute, a leader in biomedical breakthroughs headquartered in Philadelphia, is one of the nation’s top drivers of innovation, research, and tech transfer toward a stronger economy, according to the…
Read more
|

Dr. Maureen Murphy: Scientist and Teacher

Wistar offers the perfect blend of qualities for cancer researchers to thrive. Challenging science paired with a social cause is the winning formula that propels Dr. Maureen Murphy in her quest to cure cancer. A researcher for over 25 years, Murph…
Read more
|

“The London Patient” Adam Castillejo Speaks at William Way Community Center to Spread Hope for a Future HIV Cure

PHILADELPHIA—(October 20, 2022)— William Way Community Center, Philadelphia FIGHT, BEAT-HIV Delaney Collaboratory, Philadelphia Foundation, The Penn Center for AIDS Research, and The Wistar Institute are proud to announce that “The London Patient”…
Read more
|

STEM Night at R.W. Brown Boys and Girls Club: Exploring Our Roots with DNA

Dr. Jason Diaz, The Wistar Institute education program director, moved around R.W. Brown Community Center classroom full of aquariums with turtles and fish, assorted plants, and books. Dr. Diaz’s excitement was obvious as he peppered the high scho…
Read more
|

Wistar Scientists Identify Link Between Mitochondria and Pancreatic Cancer Risk

PHILADELPHIA — (OCTOBER 12, 2022) — The mitochondria is a key energy-producing component of the human cell that plays an important role in cancer cell metabolism. In a research paper published in PLOS ONE, Dario C. Altieri, M.D., president and chi…
Read more
|

Up in (Antibody) Arms: Synthetic DNA Immunotherapy Platform Combats Brain Cancer

Researchers in the Weiner Lab developed DNA-launched bispecific T cell engagers that controlled tumor growth and improved survival in glioblastoma. Glioblastoma is one of the most severe and aggressive forms of brain cancer with limited treatment …
Read more
|

[Virtual] Distinguished Lectures in Cancer Research Series: Target Discovery in the Glioblastoma Tumor Microenvironment

Scientific Seminar Tuesday, Oct. 11, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of The Wistar Institute Cancer Center and features national and international leaders in basic an…
Read more
|

Women & Science Virtual Helen Dean King Award Ceremony: What the Sugar Coating on Your Cells is Trying to Tell You

Special Event Thursday, Nov. 17, 2022 5:00 p.m. to 6:00 p.m. Join us for our virtual Women and Science event! Recognizing Outstanding Women In Biomedical Research HELEN D. KING AWARD VIRTUAL EVENT Carolyn Bertozzi, Ph.D., 2022 Nobel Prize Laureate…
Read more
|

Wistar’s Dr. Amelia Escolano Earns NIH Director’s New Innovator Award

PHILADELPHIA — (OCTOBER 4, 2022) — The National Institutes of Health has awarded Amelia Escolano, Ph.D., assistant professor in The Wistar Institute’s Vaccine & Immunotherapy Center, the 2022 NIH Director’s New Innovator Award. The honor provi…
Read more